Literature DB >> 28271232

Gastric tumours in FAP.

Sarah-Jane Walton1,2, Ian M Frayling3, Susan K Clark4,5, Andrew Latchford4,5.   

Abstract

Gastric cancer is not a recognised extra-colonic manifestation of FAP, except in countries with a high prevalence of gastric cancer. Data regarding gastric adenomas in FAP are sparse. The aim of this study was to review the clinical characteristics of gastric tumours occurring within an FAP population from the largest European polyposis registry. All patients that developed a gastric adenoma or carcinoma were identified from a prospectively maintained registry database. The primary outcome measure was the occurrence of gastric adenoma or adenocarcinoma. Secondary outcomes included APC mutation, tumour stage, management and survival. Eight patients developed gastric cancer and 21 an adenoma (median age 52 and 44 years, respectively). Regular oesophagogastroduodenoscopy surveillance was performed in 6/8 patients who developed cancer. Half were advanced T3/4 tumours and 6/8 had nodal or metastatic spread at diagnosis. All cancer cases died within a median of 13.5 months from diagnosis. Gastric adenomas were evenly distributed: 11/21 (52%) in the distal and 10/21 (48%) proximal stomach, whereas 5/8 (63%) cancers were located proximally. An association between gastric tumour and desmoid development was observed; 7/8 (88%) cancer and 11/21 (52%) adenoma cases had a personal or family history of desmoid. It would appear from this small, retrospective study that gastric cancer is not a prominent extra-colonic feature of FAP in the Western world. It seems to present at an advanced stage with a poor prognosis. There may be an association between gastric tumour and desmoid occurrence but a large multicentre cohort is necessary to investigate this further.

Entities:  

Keywords:  Desmoid; Familial adenomatous polyposis; Gastric adenoma; Gastric cancer

Mesh:

Year:  2017        PMID: 28271232     DOI: 10.1007/s10689-017-9966-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  28 in total

1.  Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps.

Authors:  R G Sarre; A G Frost; D G Jagelman; R E Petras; M V Sivak; E McGannon
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

Review 2.  The ABC of APC.

Authors:  N S Fearnhead; M P Britton; W F Bodmer
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

3.  Mortality in patients with familial adenomatous polyposis.

Authors:  M L Arvanitis; D G Jagelman; V W Fazio; I C Lavery; E McGannon
Journal:  Dis Colon Rectum       Date:  1990-08       Impact factor: 4.585

4.  Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis.

Authors:  S Nakamura; T Matsumoto; Y Kobori; M Iida
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

5.  Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.

Authors:  Michael Crabtree; Oliver M Sieber; Lara Lipton; Shirley V Hodgson; Hanan Lamlum; Hunu J W Thomas; Kay Neale; Robin K S Phillips; Karl Heinimann; Ian P M Tomlinson
Journal:  Oncogene       Date:  2003-07-03       Impact factor: 9.867

6.  Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee.

Authors:  L Bertario; S Presciuttini; P Sala; C Rossetti; M Pietroiusti
Journal:  Semin Surg Oncol       Date:  1994 May-Jun

7.  Fundic gland polyp dysplasia is common in familial adenomatous polyposis.

Authors:  Laura K Bianchi; Carol A Burke; Ana E Bennett; Rocio Lopez; Hennie Hasson; James M Church
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02       Impact factor: 11.382

8.  Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases.

Authors:  J G Park; K J Park; Y O Ahn; I S Song; K W Choi; H Y Moon; S Y Choo; J P Kim
Journal:  Dis Colon Rectum       Date:  1992-10       Impact factor: 4.585

9.  The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.

Authors:  T Iwama; Y Mishima; J Utsunomiya
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

10.  Intra-abdominal fibromatosis after gastrectomy for gastric cancer.

Authors:  Pyeong-Su Kim; Dong-Seok Han; Hye-Seung Han; Ho Yoon Bang
Journal:  Ann Surg Treat Res       Date:  2014-11-28       Impact factor: 1.859

View more
  12 in total

1.  Role of endoscopy in patients with familial adenomatous polyposis.

Authors:  Andrew D Hopper
Journal:  Frontline Gastroenterol       Date:  2022-06-08

2.  Endoscopic findings of gastric neoplasms in familial adenomatous polyposis are associated with the phenotypic variations and grades of dysplasia.

Authors:  Mayu Kobashi; Masaya Iwamuro; Sakiko Kuraoka; Shoko Inoo; Shotaro Okanoue; Takuya Satomi; Kenta Hamada; Makoto Abe; Yoshiyasu Kono; Hiromitsu Kanzaki; Seiji Kawano; Takehiro Tanaka; Yoshiro Kawahara; Hiroyuki Okada
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

Review 3.  Practical management of polyposis syndromes.

Authors:  Roshani Patel; Warren Hyer
Journal:  Frontline Gastroenterol       Date:  2019-03-30

4.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

5.  Genetic Gastric Cancer Risk Syndromes.

Authors:  Benjamin A Lerner; Xavier Llor
Journal:  Curr Treat Options Gastroenterol       Date:  2020-10-19

Review 6.  The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.

Authors:  Dimakatso Alice Senthebane; Arielle Rowe; Nicholas Ekow Thomford; Hendrina Shipanga; Daniella Munro; Mohammad A M Al Mazeedi; Hashim A M Almazyadi; Karlien Kallmeyer; Collet Dandara; Michael S Pepper; M Iqbal Parker; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

7.  Isoperistaltic Jejunal Loop Interposition after Total Gastrectomy for Gastric Cancer in Patients with Familial Adenomatous Polyposis.

Authors:  Matteo Zuin; Francesco Celotto; Salvatore Pucciarelli; Emanuele Damiano Luca Urso
Journal:  J Gastric Cancer       Date:  2020-04-13       Impact factor: 3.720

8.  Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.

Authors:  Mara Fornasarig; Raffaella Magris; Valli De Re; Ettore Bidoli; Vincenzo Canzonieri; Stefania Maiero; Alessandra Viel; Renato Cannizzaro
Journal:  Int J Mol Sci       Date:  2018-06-06       Impact factor: 5.923

Review 9.  Gastritis, Gastric Polyps and Gastric Cancer.

Authors:  Helge Waldum; Reidar Fossmark
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

10.  Genetic alteration of colorectal adenoma-carcinoma sequence among gastric adenocarcinoma and dysplastic lesions in a patient with attenuated familial adenomatous polyposis.

Authors:  Hiroki Tanabe; Kentaro Moriichi; Keitaro Takahashi; Yusuke Ono; Yu Kobayashi; Yuki Murakami; Takuya Iwama; Takehito Kunogi; Takahiro Sasaki; Katsuyoshi Ando; Nobuhiro Ueno; Shin Kashima; Hidehiro Takei; Yusuke Mizukami; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Mol Genet Genomic Med       Date:  2020-06-16       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.